How Ovarian Cancer Hijacks the Body's Own Cells to Spread: New Research Reveals a Sinister Mechanism

A Sinister Partnership Uncovered

Ovarian cancer has long been one of the deadliest forms of the disease, in large part because it tends to spread rapidly through the abdominal cavity before it is detected. Now, two studies published in early 2026 have revealed a key reason why: the cancer does not simply invade surrounding tissues on its own. Instead, it recruits the body's own protective cells to serve as unwitting accomplices in its spread.

Research from Nagoya University, published in Science Advances, found that ovarian cancer cells co-opt mesothelial cells, the protective lining of the peritoneal cavity, to form hybrid spherical clusters within the fluid that accumulates in the abdomen. Approximately 60 percent of cancer spheres examined contained these recruited mesothelial cells. Far from being passive bystanders, the recruited cells actively participate in tissue invasion.

The Organ-Level Transformation

A complementary study from the University of Basel and University Hospital Basel investigated what happens to the omentum, a fatty tissue apron in the abdomen that is a primary target for ovarian cancer metastasis. The researchers found that when cancer cells migrate into the omentum, they do not merely establish colonies. They transform the entire organ.

The cancer hijacks the omentum's normal tissue architecture, replacing it with an environment that favors tumor growth. The transformation includes an increase in immune cells that dampen the immune system's ability to attack tumor cells, effectively turning the body's defenses into the cancer's allies. The result is the loss of the omentum's normal structure and regenerative capacity.

Implications for Treatment

These findings have immediate clinical implications. The Basel researchers suggest that surgical removal of the omentum during treatment should be more extensive than current practice often dictates. Rather than removing only the visibly diseased portion, removing a larger section of apparently healthy omentum may reduce the risk of cancer recurrence by eliminating tissue that has already been reprogrammed by the cancer at a molecular level, even if it appears normal to the naked eye.

The Nagoya University findings point toward different therapeutic possibilities. Understanding how cancer cells recruit mesothelial cells could lead to treatments that block this recruitment process, potentially slowing or preventing the formation of the invasive hybrid clusters that drive metastasis. If scientists can disrupt the molecular signals that cancer cells use to co-opt their neighbors, they may be able to contain the spread at its earliest stages.

A Global Health Priority

Ovarian cancer affects approximately 314,000 women worldwide each year and claims roughly 207,000 lives. It is often diagnosed at advanced stages because early symptoms are vague and easily attributed to other conditions. The five-year survival rate for advanced ovarian cancer remains stubbornly low, underscoring the need for improved understanding of how the disease spreads and new strategies to combat it.

By revealing the specific cellular mechanisms that make ovarian cancer so adept at colonizing the abdomen, these studies provide the foundational knowledge needed to develop more targeted and effective interventions. The cancer's strategy of turning the body against itself is now better understood, and that understanding is the first step toward defeating it.